A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2-positive Breast Cancer
Clinical trial NCT06234137 · RECRUITING
Trial details
- NCT number
- NCT06234137
- Sponsor
- Wang Ouchen
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-27
- Primary completion
- 2025-07-31
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.